Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biomanufacturing
Biotech
iBio champions AI-fueled obesity pivot as 1st asset hits clinic
Upon finally reaching the clinic, iBio feels vindicated about the artificial intelligence-powered discovery platform it picked up in 2022.
Fraiser Kansteiner
Jun 26, 2026 5:00am
Manufacturer Emergent invests in next-gen vax biotech
Mar 12, 2025 10:22am
MIT cell-engineering spinout nets $30M for production platform
Sep 28, 2021 11:55am
Massachusetts biopharmas raise $4.3B in 1Q
Aug 25, 2021 8:51am
Debut Biotech snags $22M for cell-free biomanufacturing facility
Aug 12, 2021 9:00am
Lumen teams with Google to help grow drug-producing algae
Aug 11, 2021 8:00am
